bioRxivBiophysicsPreprint
Identification of Catechins Binding Pockets in Monomeric Aβ42 Through Ensemble Docking and MD Simulations
C. Chavez Gracia, R. Firouzi, S. Sowlati-Hashjin, M. Ashouri, M. H. Karimi-Jafari, M. Karttunen
Abstract
The assembly of the Amyloid-{beta} peptide (A{beta}) into toxic oligomers and fibrils is associated with Alzheimers disease and dementia. Therefore, disrupting amyloid assembly by direct targeting of the A{beta} monomeric form with small molecules or antibodies is a promising therapeutic strategy. However, given the dynamic nature of A{beta}, standard computational tools cannot be easily applied for high-throughput structure-based virtual screening in drug discovery projects. In the current study, we propose a computational pipeline - in the framework of the ensemble docking strategy - to identify catechins binding pockets in monomeric A{beta}42. It is shown that both hydrophobic aromatic interactions and hydrogen bonding are crucial for the binding of catechins to A{beta}42. Also, it has been found that all the studied ligands, especially the EGCG, can act as potent inhibitors against amyloid aggregation by blocking the central hydrophobic region of the A{beta}. Our findings are evaluated and confirmed with multi-microsecond MD simulations. Finally, it is suggested that our proposed pipeline, with low computational cost in comparison with MD simulations, is a suitable approach for the virtual screening of ligand libraries against A{beta}.
- assay: protein structure
- research focus: drug response / drug discovery
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In silico identification of novel peptides as potential modulators of Aβ42 Amyloidogenesis
Kavita Kundal, Santhosh Paramasivam, … Nandini Sarkar·bioRxiv·Apr 20, 2022
- Small molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease
G. T. Heller, F. A. Aprile, … M. Vendruscolo·bioRxiv·Sep 16, 2020
- The Role of Binding Site Specificity in the Disaggregation of Aβ42 Fibrils through a Synthetic Paratope
S. Tiwari, B. Mandal, K. Anki Reddy·bioRxiv·Aug 11, 2023
- The monomeric conformational ensembles of Aβ40 and Aβ42 encode their differential amyloid aggregation propensity
Irene Cadenelli, Andrea Ciccolo, … Davide Bochicchio·The Journal of Physical Chemistry BPeer-reviewed·Jun 9, 2026
- Interactions of curcumin's degradation products with the Aβ42 dimer: A computational study
Maryam Haji Dehabadi, Amedeo Caflisch, … Rohoullah Firouzi·The Journal of Physical Chemistry BPeer-reviewed·Sep 23, 2022
- Kinetic fingerprints differentiate anti-Aβ therapies
S. Linse, T. Scheidt, … O. Hansson·bioRxiv·Feb 27, 2020